{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:03:31Z","timestamp":1790370211741,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.bulcan.2026.07.006","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T20:32:29Z","timestamp":1790368349000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Suivi \u00e0 long terme des patients adultes allogreff\u00e9s\u00a0\u2013\u00a0SFGM-TC"],"prefix":"10.1016","author":[{"given":"Tereza","family":"Coman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Andreozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Caudron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Anne","family":"Couturier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Landreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laure","family":"Tardieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rabah","family":"Rejoul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Marzloff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Huynh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Magro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Chevallier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Berceanu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bulcan.2026.07.006_bib0160","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/bmt.2016.20","article-title":"Hematopoietic stem cell transplantation in Europe 2014: more than 40,000\u00a0transplants annually","volume":"51","author":"Passweg","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bulcan.2026.07.006_bib0165","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.bbmt.2017.01.001","article-title":"Reprint of: long-term survivorship after hematopoietic cell transplantation: roadmap for research and care","volume":"23","author":"Battiwalla","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bulcan.2026.07.006_bib0170","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/s41409-023-02190-2","article-title":"International recommendations for screening and preventative practices for long-term survivors of transplantation and cellular therapy: a 2023\u00a0update","volume":"59","author":"Rotz","year":"2024","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bulcan.2026.07.006_bib0175","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/978-1-0716-4430-0_5","article-title":"Assessment of survivorship in allogeneic hematopoietic stem cell transplantation","volume":"2907","author":"McErlean","year":"2025","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.bulcan.2026.07.006_bib0180","doi-asserted-by":"crossref","first-page":"614","DOI":"10.3324\/haematol.2016.150250","article-title":"Late effects of blood and marrow transplantation","volume":"102","author":"Inamoto","year":"2017","journal-title":"Haematologica"},{"key":"10.1016\/j.bulcan.2026.07.006_bib0185","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2147\/JBM.S206027","article-title":"Optimal delivery of follow-up care after allogeneic hematopoietic stem-cell transplant: improving patient outcomes with a multidisciplinary approach","volume":"11","author":"Giaccone","year":"2020","journal-title":"J Blood Med"},{"key":"10.1016\/j.bulcan.2026.07.006_bib0190","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1038\/s41571-023-00776-9","article-title":"Mitigating long-term and delayed adverse events associated with cancer treatment: implications for survivorship","volume":"20","author":"Lustberg","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.bulcan.2026.07.006_bib0195","doi-asserted-by":"crossref","first-page":"S193","DOI":"10.1016\/j.bulcan.2016.09.006","article-title":"How we harmonize HSCT clinical practices among the SFGM-TC centers","volume":"103","author":"Tipton","year":"2016","journal-title":"Bull Cancer"},{"key":"10.1016\/j.bulcan.2026.07.006_bib0200","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.bbmt.2011.03.008","article-title":"Allogeneic transplant physician and center capacity in the United States","volume":"17","author":"Majhail","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bulcan.2026.07.006_bib0205","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/imj.12336","article-title":"Health status, late effects and long-term survivorship of allogeneic bone marrow transplantation: a retrospective study","volume":"44","author":"Gifford","year":"2014","journal-title":"Intern Med J"},{"key":"10.1016\/j.bulcan.2026.07.006_bib0210","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1038\/bmt.2016.135","article-title":"The experience of survival following allogeneic haematopoietic stem cell transplantation in New South Wales, Australia","volume":"51","author":"Gifford","year":"2016","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bulcan.2026.07.006_bib0215","series-title":"The EBMT Handbook: hematopoietic stem cell transplantation and cellular therapies","article-title":"JACIE accreditation of HSCT programs","author":"Saccardi","year":"2019"},{"key":"10.1016\/j.bulcan.2026.07.006_bib0220","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.bbmt.2016.10.011","article-title":"Late complications and quality of life after reduced-intensity conditioning allogeneic stem cell transplantation","volume":"23","author":"Clavert","year":"2017","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bulcan.2026.07.006_bib0225","doi-asserted-by":"crossref","first-page":"1175794","DOI":"10.3389\/fonc.2023.1175794","article-title":"Long-term health outcomes of allogeneic hematopoietic stem cell transplantation","volume":"13","author":"Kelkar","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.bulcan.2026.07.006_bib0230","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13770-018-0157-3","article-title":"Late complications of allogenic stem cells transplantation in leukaemia","volume":"16","author":"Kanagasundram","year":"2019","journal-title":"Tissue Eng Regen Med"},{"key":"10.1016\/j.bulcan.2026.07.006_bib0235","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s11899-023-00694-8","article-title":"Managing survivorship after hematopoietic cell transplantation","volume":"18","author":"Khera","year":"2023","journal-title":"Curr Hematol Malig Rep"},{"key":"10.1016\/j.bulcan.2026.07.006_bib0240","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1038\/s41409-020-01067-y","article-title":"Survivorship care for allogeneic transplant patients in the UK NHS: changes centre practice, impact of health service policy and JACIE accreditation over 5\u00a0years","volume":"56","author":"Dignan","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.bulcan.2026.07.006_bib0245","doi-asserted-by":"crossref","first-page":"3784","DOI":"10.1182\/blood-2007-03-082933","article-title":"Late mortality after allogeneic hematopoietic cell transplantation and functional status of long-term survivors: report from the Bone Marrow Transplant Survivor Study","volume":"110","author":"Bhatia","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.bulcan.2026.07.006_bib0250","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1200\/JCO.2009.25.6693","article-title":"Life expectancy in patients surviving more than 5\u00a0years after hematopoietic cell transplantation","volume":"28","author":"Martin","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.bulcan.2026.07.006_bib0255","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.jaccao.2024.06.004","article-title":"Cardiovascular disease after hematopoietic stem cell transplantation in adults: JACC: CardioOncology State-of-the-Art Review","volume":"6","author":"Gent","year":"2024","journal-title":"JACC CardioOncol"},{"key":"10.1016\/j.bulcan.2026.07.006_bib0260","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1182\/blood-2010-10-263095","article-title":"treat late effects in adults after allogeneic stem cell transplantation","volume":"117","author":"Savani","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.bulcan.2026.07.006_bib0265","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.bbmt.2014.06.035","article-title":"Lost in transition: the essential need for long-term follow-up clinic for blood and marrow transplantation survivors","volume":"21","author":"Hashmi","year":"2015","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bulcan.2026.07.006_bib0270","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/978-3-031-84988-6_12","article-title":"Challenges and opportunities in the care of hematopoietic cell transplant survivors in the modern era","volume":"1475","author":"Bhatt","year":"2025","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.bulcan.2026.07.006_bib0275","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","article-title":"2022\u00a0ESC Guidelines on cardio-oncology developed in collaboration with the European Hematology Association (EHA), the European Society for Therapeutic Radiology and Oncology (ESTRO) and the International Cardio-Oncology Society (IC-OS)","volume":"43","author":"Lyon","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/j.bulcan.2026.07.006_bib0280","series-title":"The EBMT Handbook: hematopoietic stem cell transplantation and cellular therapies","article-title":"Short- and long-term controls after HSCT","author":"Rovira","year":"2019"},{"key":"10.1016\/j.bulcan.2026.07.006_bib0285","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1016\/j.bulcan.2023.05.007","article-title":"Vaccination of allogeneic haematopoietic stem cell transplant recipients: guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC)","volume":"111","author":"Conrad","year":"2024","journal-title":"Bull Cancer"},{"issue":"6","key":"10.1016\/j.bulcan.2026.07.006_bib0290","doi-asserted-by":"crossref","first-page":"325.e1","DOI":"10.1016\/j.jtct.2022.03.014","article-title":"Long-term survival after hematopoietic cell translantation for sickle cell disease compared to the United States population","volume":"28","author":"Martin","year":"2022","journal-title":"Transplant Cell Ther"},{"key":"10.1016\/j.bulcan.2026.07.006_bib0295","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/S2352-3026(23)00342-3","article-title":"Prophylaxis and management of graft-versus-host disease after stem-cell transplantation for haematological malignancies: updated consensus recommendations of the European Society for Blood and Marrow Transplantation","volume":"11","author":"Penack","year":"2024","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.bulcan.2026.07.006_bib0300","doi-asserted-by":"crossref","first-page":"e70026","DOI":"10.1002\/hem3.70026","article-title":"Long-term outcome of 2-year survivors after allogeneic hematopoietic cell transplantation for acute leukemia","volume":"8","author":"Larue","year":"2024","journal-title":"Hemasphere"},{"key":"10.1016\/j.bulcan.2026.07.006_bib0305","doi-asserted-by":"crossref","first-page":"431","DOI":"10.3324\/haematol.2023.283175","article-title":"Allogeneic hematopoietic stem cell transplantation in patients aged 60\u201379\u00a0years in Germany (1998\u20132018): a registry study","volume":"109","author":"Weller","year":"2024","journal-title":"Haematologica"},{"key":"10.1016\/j.bulcan.2026.07.006_bib0155","article-title":"Immunoglobulin replacement to prevent infections in people with haematological malignancies and haematopoietic stem cell transplantation","author":"Chai","year":"2024","journal-title":"Cochrane Database Syst Rev"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455126003863?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455126003863?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T20:32:34Z","timestamp":1790368354000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455126003863"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":31,"alternative-id":["S0007455126003863"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2026.07.006","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Suivi \u00e0 long terme des patients adultes allogreff\u00e9s\u00a0\u2013\u00a0SFGM-TC","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2026.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer. Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}